estrogen receptor positive breast cancer

Showing 1 - 16 of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Estrogen Receptor Positive Breast Cancer, Breast Cancer Trial in Houston (ESTRING, Replens)

Recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
Nov 18, 2022

Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma Trial in Canada,

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • +7 more
  • Birmingham, Alabama
  • +499 more
Nov 15, 2022

FDG PET/CT in Breast Cancer Bone Mets

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Bone Metastases
  • FDG PET/CT scan
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Oct 13, 2022

Estrogen Receptor Positive Breast Cancer Trial in United Kingdom (AZD5363, Placebo, Fulvestrant)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Manchester, Greater Manchester, United Kingdom
  • +20 more
Aug 5, 2022

Estrogen Receptor Positive Breast Cancer, Breast Tumor, Metastatic Breast Cancer Trial in Philadelphia ([18F]FES)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Jul 5, 2022

Estrogen Receptor Positive Breast Cancer Trial in Salt Lake City ([18F]Fluoroestradiol (FES) PET/CT)

Recruiting
  • Estrogen Receptor Positive Breast Cancer
  • [18F]Fluoroestradiol (FES) PET/CT
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Apr 21, 2022

Breast Cancer, Estrogen Receptor Positive Breast Cancer, Node-negative Breast Cancer Trial in Boston (Breast Cancer Treatment

Completed
  • Breast Cancer
  • +3 more
  • Breast Cancer Treatment Decision Aid for women 70+
  • Usual Care
  • Boston, Massachusetts
  • +1 more
Mar 10, 2022

HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Worldwide (palbociclib, trastuzumab, pertuzumab)

Active, not recruiting
  • HER-2 Positive Breast Cancer
  • Estrogen Receptor Positive Breast Cancer
  • San Francisco, California
  • +106 more
Mar 16, 2022

Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Denver, Sarasota, Nashville (entinostat, exemestane)

Completed
  • Breast Cancer
  • Estrogen Receptor Positive Breast Cancer
  • Denver, Colorado
  • +2 more
Dec 14, 2021

Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

Completed
  • Estrogen Receptor Positive Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer Trial in Worldwide

Completed
  • Advanced Solid Tumors With an Alteration of the PIK3CA Gene
  • Estrogen Receptor Positive Breast Cancer
  • San Francisco, California
  • +10 more
Sep 21, 2020

Estrogen Receptor Positive Breast Cancer Trial in Worldwide (AZD2014, Everolimus, Fulvestrant)

Unknown status
  • Estrogen Receptor Positive Breast Cancer
  • Angers, France
  • +78 more
Feb 24, 2020

Invasive Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Seoul

Unknown status
  • Invasive Breast Cancer
  • Estrogen Receptor Positive Breast Cancer
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Apr 17, 2018

    Estrogen Receptor Positive Breast Cancer Trial in Goodyear (hydroxychloroquine)

    Terminated
    • Estrogen Receptor Positive Breast Cancer
    • Goodyear, Arizona
      Western Regional Medical Center, Inc.
    Sep 25, 2017

    Metastatic Breastcancer, Estrogen Receptor Positive Breast Cancer, Estrogen Receptor Negative Tumor Trial in Italy (DHEA)

    Terminated
    • Metastatic Breastcancer
    • +5 more
    • Meldola, FC, Italy
    • +7 more
    Sep 28, 2016